Exploring Patient Perspectives on NASH Drug Development

Time: 5:00 pm
day: Day Two

Details:

• Understanding the importance of patient involvement in clinical trial design and protocol review
• Learning why it’s important to prioritize consistent messaging and planning via GLI’s Language of NASH and US NASH Action Plan
• Uncovering insights from GLI’s recent FDA NASH Patient-Focused Drug Development Symposium and NASH patient survey

Speakers: